FDA approves Abbott’s new stent system
BY FRANCINE KNOWLES Business Reporter firstname.lastname@example.org January 3, 2013 10:12AM
Updated: April 15, 2013 7:00AM
North Chicago-based Abbott’s Xience Xpedition stent system received approval from the U.S. Food and Drug Administration and will launch sales immediately in the U.S., the company said Thursday.
The stent system provides “physicians with a next-generation technology with the largest size matrix in the U.S. market,” the company said.
Stents are used to prop open blocked arteries.
The Xience Xpedition stent features a new stent delivery system. Abbott’s Xience drug-eluting stents, including the new Xpedition, are the first and only in the U.S. market proven safe for direct stenting, which doesn’t use another device, such as a balloon dilatation catheter. And that can save time, Abbott said.
“The launch of Xience Xpedition in the United States will advance Abbott’s worldwide market-leading position in drug-eluting stents,” Abbott’s John Capek, executive vice president, medical devices, said in a statement.